These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6286147)

  • 21. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells.
    Rickinson AB; Wallace LE; Epstein MA
    Nature; 1980 Feb; 283(5750):865-7. PubMed ID: 6244495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity.
    Itoh K; Balch CM; Platsoucas CD
    Cell Immunol; 1987 Sep; 108(2):313-22. PubMed ID: 3113742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
    Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
    Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
    [No Abstract]   [Full Text] [Related]  

  • 26. LFA-1 and Lyt-2,3, molecules associated with T lymphocyte-mediated killing; and Mac-1, an LFA-1 homologue associated with complement receptor function.
    Springer TA; Davignon D; Ho MK; Kürzinger K; Martz E; Sanchez-Madrid F
    Immunol Rev; 1982; 68():171-95. PubMed ID: 6184305
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of alloantigen-activated human lymphocytes cytotoxic for autologous EB virus-transformed lymphoblastoid cell lines.
    Zarling JM
    Transplant Proc; 1981 Dec; 13(4):1893-6. PubMed ID: 6277059
    [No Abstract]   [Full Text] [Related]  

  • 28. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human monoclonal antibodies against surface antigens of Langerhans cells from lymphocytes of diabetics transformed by Epstein-Barr virus].
    Thivolet C; Desgranges C; Durand A; Bertrand J
    C R Acad Sci III; 1985; 301(13):611-4. PubMed ID: 3004677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
    Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
    J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-transformed oligoclonal B cell lines producing a cytotoxic human autoantibody.
    Weber BK; al-Muzairai IA; Power DA
    Transplantation; 1991 Mar; 51(3):728-30. PubMed ID: 1848732
    [No Abstract]   [Full Text] [Related]  

  • 32. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of monoclonal antibodies against lymphocyte surface antigens on interleukin 2 excretion by Epstein-Barr virus-specific human T-cell hybridomas.
    Lakow ES; Valentine MA; Vaughan JH; Tsoukas CD; Carson DA
    Cell Immunol; 1984 Apr; 85(1):67-74. PubMed ID: 6325024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus.
    Rosenthal KS; Shuman H; Strominger JL
    J Immunol; 1981 Aug; 127(2):746-54. PubMed ID: 6166685
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.
    Landegren U; Ramstedt U; Axberg I; Ullberg M; Jondal M; Wigzell H
    J Exp Med; 1982 May; 155(5):1579-84. PubMed ID: 6978378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation.
    Allen DJ; Rickinson AB; Wallace LE; Rowe M; Moss DJ; Epstein MA
    Cell Immunol; 1982 Feb; 67(1):141-51. PubMed ID: 6176333
    [No Abstract]   [Full Text] [Related]  

  • 38. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
    Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
    Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human T cell mediated cytolysis by monoclonal antibodies to effector cell surface structures.
    Malissen B; Mawas C; Rebai N
    Adv Exp Med Biol; 1982; 146():563-73. PubMed ID: 6980575
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line.
    Gras GS; Dormont D
    J Virol; 1991 Jan; 65(1):541-5. PubMed ID: 1845908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.